FA(18:2)
|
Basic information |
| Metabolite name | FA(18:2) |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | NA |
| No. of studies | 4 |
|
Relationship between FA(18:2) and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M887 | Type1 | CUMS group vs. control group | Serum | C57BL/6J mouse | Down |
| Study M888 | Type1 | CUMS microbiota group vs. control microbiota group | Serum | C57BL/6J mouse | Down |
| Study M888 | Type2 | CUMS microbiota + L. plantarum Lp group vs. CUMS microbiota group | Hippocampus | C57BL/6J mouse | Up |
| Study M888 | Type2 | CUMS microbiota + arachidonic acid group vs. CUMS microbiota group | Hippocampus | C57BL/6J mouse | Up |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Plasma | Human | Down |
| Study M962 | Type2 | 24h-post ketamine infusion vs. baseline | Plasma | Human | Down |